For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Scipher Medicine Corporation

USPTO Granted Patents = 9

EPO Patents = 1

Trademarks = 2

Forward Citations = 16

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Keith J Johnson (7 out of 7 patents)

Susan Dina Ghiassian (6 out of 6 patents)

Viatcheslav R Akmaev (6 out of 13 patents)

4. Theodore R Mellors (5 out of 5 patents)

5. Marc Santolini (5 out of 5 patents)

6. Asher Ameli (5 out of 5 patents)

7. Nancy J Schoenbrunner (5 out of 29 patents)

8. Susan Ghiassian (2 out of 2 patents)

9. Italo Faria Do Valle (1 out of 1 patent)

10. Deisy Morselli Gysi (1 out of 1 patent)

11. Onur Varol (1 out of 1 patent)

12. Xiao Gan (1 out of 1 patent)

13. Marinka Zitnik (1 out of 1 patent)

14. Lixia Zhang (1 out of 1 patent)

15. Joseph Loscalzo (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12670969 - Network medicine framework for identifying drug repurposing opportunities (2026-06-30),

2. 12525318 - Method of monitoring anti-TNF therapy in a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier (2026-01-13),

3. 12062415 - Methods of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based in part on a trained machine learning classifier (2024-08-13),

4. 12046338 - Assessing responsiveness to therapy (2024-07-23),

5. 11987620 - Methods of treating a subject with an alternative to anti-TNF therapy (2024-05-21),

6. 11783913 - Methods of treating a subject suffering from rheumatoid arthritis with alternative to anti-TNF therapy based in part on a trained machine learning classifier (2023-10-10),

7. 11456056 - Methods of treating a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier (2022-09-27),

8. 11198727 - Methods and systems for predicting response to anti-TNF therapies (2021-12-14),

9. 11195595 - Method of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based on a trained machine learning classifier (2021-12-07),

Company Overview

Scipher Medicine is a precision immunology company that leverages its proprietary platform to develop personalized therapies for patients with autoimmune diseases. Their innovative approach aims to predict, diagnose, and treat patients based on their unique immune system profiles to improve outcomes and reduce healthcare costs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

9 Patents

#136 in Waltham, MA

#1,924 in Massachusetts

#32,565 in US

Waltham, MA, United States of America

Scipher Medicine Corporation

Forward Citations = 16

17 inventors:

Keith J Johnson (7 out of 7 patents)

Susan Dina Ghiassian (6 out of 6 patents)

Viatcheslav R Akmaev (6 out of 13 patents)

4. Theodore R Mellors (5 out of 5 patents)

5. Marc Santolini (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scipher Medicine Corporation. Retrieved from https://idiyas.com/company/scipher-medicine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Please report any incorrect information to [email protected]

Loading…